Company attributes
B2X
CEO
Founder
Legal Name
Burning Rock Biotech Limited
Parent Organization
Subsidiary
Legal classification
Number of Employees (Ranges)
1,001 – 5,0000
Email Address
Phone Number
Full Address
601, 6/F, Building 3, Standard Industrial Unit 2 No. 7, Luoxuan 4th Road International Bio Island, Guangzhou, 510005 People’s Republic of China
CIK Number
Investors
Founded Date
2014
0Total Funding Amount (USD)
369,151,750
Latest Funding Round Date
2019
Stock Symbol
BRN0
Exchange
Latest Funding Type
Legal Entity Identifier
Country
Headquarters
Other attributes
Company Operating Status
Active
Latest Funding Round Amount (USD)
131,400,000
Wikidata ID
Burning Rock Biotech is a developer of next generation sequencing (NGS) technology for the field of precision oncology. The company develops NGS-based therapy selection testing for late-stage cancer patients and NGS-based cancer early detection systems.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Patents
Further Resources
No Further Resources data yet.
